Skip to main content
Have a personal or library account? Click to login
SARS-CoV2 Infection in a Multiple Sclerosis Patient Treated with Natalizumab – A Case Presentation Cover

SARS-CoV2 Infection in a Multiple Sclerosis Patient Treated with Natalizumab – A Case Presentation

Acta Marisiensis - Seria Medica
Volume 66 (2020): Issue 3 (September 2020)
By:  and    
Open Access
|Sep 2020
Authors

Authors

Georgiana Șerban

georgiana.serban94@yahoo.com

George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania

Rodica Bălașa

George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania
DOI: https://doi.org/10.2478/amma-2020-0022 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 110 - 112
Submitted on: Aug 20, 2020
Accepted on: Sep 1, 2020
Published on: Sep 29, 2020
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
multiple sclerosis,
Natalizumab,
SARS-CoV2 infection,
COVID-19 outbreak
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2020 Georgiana Șerban, Rodica Bălașa, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 66 (2020): Issue 3 (September 2020)
Previous article
Next article